HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

Similar documents
Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

How do we treat migraine? New SIGN Guidelines

Treatments for migraine

Management of headache

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

Strategies in Migraine Care

COMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS

Treatment of Primary Headache Syndromes

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

ADVANCES IN MIGRAINE MANAGEMENT

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Disclosures. Triptans for Kids 5/16/13

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM

Update on Diagnosis and Management of Migraines

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

Headache A Practical Approach

10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD

Dubai Standards of Care (Migraine)

Clinical Learning Days November 10, 2017

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

SIGN on the pharmacological management of migraine

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

Headache Questionnaire

Page: 1 of 6. Aimovig (erenumab-aooe) injection, Ajovy (fremanezumab-vfrm) injection, Emgality (galcanezumab-gnim)

TABLE 1. Current Diagnostic Criteria for Migraine Without Aura 2 A. At least 5 attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours

Preventive treatment of migraine. Rebecca Burch, MD Brigham and Women s Faulkner Hospital Harvard Medical School Boston, MA

Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

ONZETRA XSAIL (sumatriptan) nasal powder

What You Should Know About Your HEADACHE. Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache

Migraine Acute treatment

Vestibular Migraine. Information for patients and carers. Department of Neurology and Otolaryngology Aberdeen Royal Infirmary

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

Non-opioid and adjuvant pain management

Acute Migraine Treatment in Adults

Migraine in Children. Germano Falcao, MD Pediatric Neurology 03/07/2014

Abortive Agents. Available Strengths. Formulary Limits. Tablet: 5mg, 10mg ODT: 5mg, 10 mg 25mg, 50mg, 100mg. 5mg/act, 20mg/act

Acute Migraine Treatment: What you and your family should know to help you make the best choices with your doctor

Maternity. Migraine in pregnancy Information for women

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection

MEASURE #1: MEDICATION PRESCRIBED FOR ACUTE MIGRAINE ATTACK Headache

Headaches in Pregnancy Before, During, and After

Disclosures. Objectives 6/20/2018. No disclosures. Tools & Tips for Headache Management in Special Populations: The Young & Old, Pregnant & Lactating

Opioids Limitation For Quantity and Dosage

COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE

What is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary

The best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017

Concussion. James R. Borchers, MD, MPH

Triptans Quantity Limit Program Summary

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

Anti-Migraine Agents

Headaches: An Approach to Evaluation & Management

Get ahead of the ACHE: Monoclonal Antibodies in Migraine Prevention

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

Controlling Migraine Pain

My patient s pain in the head, is a pain in Greg Jicha, M.D., Ph.D.

Knock Out Opioid Abuse in New Jersey:

Understanding Migraines and Treatment Options. Simplified Diagnosis of Migraine. Migraine Prevalence American Migraine Study II

Headache. Section 1. Migraine headache. Clinical presentation

Reflections on NICE Headache Guideline. Dr Kay Kennis GPwSI in Headache, Bradford

Headaches in the Pediatric Emergency Dept

Headache evaluation and management after concussion. Assistant Professor

How could I be having migraine when I don't have a headache?

M0BCore Safety Profile. Pharmaceutical form(s)/strength: ordispersible tablet SE/H/PSUR/0022/002 Date of FAR:

Headache. Headache Case. Migraine Headache. Eric Kraus, MD. Types» Without aura (common)» With aura (classic)

ISSN doi: /head VC 2015 American Headache Society Published by Wiley Periodicals, Inc.

Triptan Quantity Limit

Migraine is a primary headache disorder ... REPORTS... Migraine: Diagnosis, Management, and New Treatment Options

Adolescent Alcohol & Drug Use: Epidemiology, Prevention, Early Intervention, & Treatment

Antidepressant Pharmacology An Overview

Headache: A case-based approach

A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN

SIGN 155 Pharmacological management of migraine. A national clinical guideline February Evidence

The Pediatric Headache Handbook

CYCLIC VOMITING SYNDROME. C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%

Lost in Translation: Making Sense of Clinical Treatment Guidelines

Headaches in Children and Adolescents. Paul Shillito

Tools & Tips for Headache Management in Special populations: The Young & Old, Pregnant & Lactating, and those with Heart or Kidney Disease

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

ABORTIVE AGENTS. Average cost per 30 days. Form Limits SEROTONIN AGONISTS $ $ Reserved for treatment failure to either Sumatriptan PA; QL

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

MIGRAINE A MYSTERY HEADACHE

10/19/2018. Disclosures MIGRAINE PROPHYLAXIS. Objectives. Definitions Slide. What do you think the aooe stands for at the end of erenumab-aooe?

Ergotamine/Dihydroergotamine Products

Incidence, prevention and treatment of migraine

Current practice and future directions in the prevention and acute management of migraine

Outpatient Headache Care Guideline

GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi

Understanding. Migraine. Amy, diagnosed in 1989, with her family.

Long-Term Care Updates

1. On how many days in the last 3 months did you miss work or school because of your headaches?

Transcription:

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in Anesthesia and Neurology Harvard Medical School

Limited time to cover a huge amount of material A high-speed approach to clinical headache management Not a presentation of the latest research Will cover principles and treatment options Patient education is the most valuable treatment modality Flexibility is essential

Anxiety, depression, bipolar disorder, borderline personality disorder Stress is a consistent/common headache trigger 1) Psychotherapy/cognitive behavioral therapy 2) Biofeedback 3) Yoga/meditation 4) Exercise 5) Pain psychology

3 months or longer of taking acute medication more than twice a week 1) Limit acute medication use to no more than twice a week (identify an appropriate alternative) 2) Begin headache prevention 3) Taper the overused medication (washout can take several months)

1) Consistent sleep schedule (treat insomnia) 2) Regular meals with healthy snacks 3) Limit caffeine use 4) Stress management 5) Obesity

Prevention indicated if a patient is experiencing two or more headaches a week Be aware of medication failures (inadequate treatment trials) Headache prevention can take 2-3 months to work and doses must be adequate Titrate dose slowly Combination therapy

Standard of therapy for many chronic medical conditions (diabetes, hypertension, HIV) Targets multiple pathophysiologic mechanisms Can address comorbidities such as depression, anxiety, bipolar disorder, insomnia Use non-pharmacologic methods as well

Beta-blocker plus TCA (depression and insomnia) Beta-blocker plus SNRI (depression and fibromyalgia) Beta-blocker plus topiramate (obesity) Topiramate plus tizanidine (insomnia) Personal preference

1) Topiramate: dose 50 mg bid. SE s include paresthesias, decreased appetite, cognitive dysfunction, kidney stones. Teratogenic (D) and can interfere with birth control. Especially useful in chronic migraine. FDA approved for episodic migraine. 2) Tizanidine: dose 6-8 mg/bedtime. SE s include sedation, rare transaminitis, nightmares. 3) Verapamil: dose 360 mg/day. SE s include hypotension, edema, constipation.

4) Valproate: dose 1,000 mg daily. SE s include gastric distress, hair loss, weight gain, tremor, rare transaminitis. Teratogenic (X for migraine prophylaxis, D for other indications). Effective in chronic daily headache. FDA approved for episodic migraine. 5) Amitriptyline: dose 50-75 mg/bedtime. SE s include sedation, dry mouth, weight gain.

6) Propranolol: dose 160-240 mg/d. SE s include hypotension, exercise intolerance, fatigue, depression. Contraindicated in asthma. FDA approved for episodic migraine. 7) Botulinum toxin Type A: dose 155 units every three months. Well-tolerated. Often used in combination therapy. FDA approved for chronic migraine. Insurance approval can be problematic. 8) Gabapentin: dose 1800-2400 mg/d. Few side effects/drug interactions.

9) Pericranial nerve blocks. 10) Nutraceuticals (nutrition/pharmaceutical) 1) Riboflavin (Vitamin B2): dose 400 mg/d. 2) Magnesium (citrate): dose 600 mg/d.

Acute treatment should be kept to no more than twice a week Treat early Tailor treatment: injectable therapy for rapid onset headaches; intranasal, injectable, or rectal routes for headache with severe nausea/vomiting Consider combinations: Triptan plus NSAID, Triptan plus antiemetic, combination of all three

It may not be possible to completely abort every headache (functionality) Less convenient but more effective nonoral medications may be necessary (nonoral formulations are generally more effective)

1) NSAIDs: ibuprofen (600-800 mg), naproxen sodium (500-1000 mg), flurbiprofen (100 mg), ketoprofen (50 mg), indomethacin (25-50 mg oral, 50 mg suppository). SE s include gastrointestinal bleeding, nausea, abdominal pain, renal disease, heart attack, and stroke. 2) Dihydroergotamine: intravenous, intramuscular, subcutaneous: 0.5-1 mg at headache onset; intranasal: 0.5 mg in each nostril, repeat in 15 minutes. Useful if combined with an NSAID or antiemetic. SE s include nausea, vomiting, muscle cramping.

3) Triptans: sumatriptan (oral, nasal spray, injection, transdermal), zolmitriptan (oral, nasal spray), rizatriptan (oral), naratriptan, frovatriptan, eletriptan, almotriptan (oral). SE s include chest discomfort and dizziness. Can combine with an NSAID. Contraindicated in patients with known cardiac disease, uncontrolled hypertension, and pregnancy. Insurance limitations. Serotonin syndrome.

4) Dopamine antagonists: a) prochlorperazine 5-10 mg po tid or 25 mg rectally; sedation and akathisia; b) metoclopramide 5-10 mg po tid, less sedating and well-tolerated; c) promethazine 25-50 mg po or rectally tid; sedation. Keep use to twice a week or less to prevent dystonia and dyskinesia. 5) Corticosteroids: useful for prolonged or severe headaches. Decadron 4 mg tid for 2-3 days, prednisone taper. Limit use to every three months.

6) Opioids: Controversial and very limited use for headache. Strict parameters when used in patients with true contraindications to appropriate therapy. Can be used in pregnancy. 7) Butalbital combination products: Avoid, please. Or use with strict limitations, if at all. 8) Acetaminophen: useful when combined with an antiemetic. Safe in pregnancy.

Diphenhydramine/hydroxyzine Dopamine antagonists Intranasal lidocaine Intravenous magnesium sulfate Occipital nerve blocks